MedTrace Logo

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

NCT05507398 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-10-31

No results posted yet for this study

Summary

This study aims at evaluating and comparing the anti-tumor effects of metformin and statins (hydroxyl-methyl-glutaryl-CoA reductase inhibitors) in patients with non-metastatic breast cancer (stage I, II, \& III).

Conditions

  • Breast Cancer Female

Interventions

DRUG

Placebo, metformin and atorvastatin

comparing the anti-tumor effects of metformin and atorvastatin

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • ahmed elabd, doctor · Tanta university, faculty of pharmacy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-07-31
Completion
2023-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05507398 on ClinicalTrials.gov